BACKGROUND: Urinary uromodulin (UMOD) predicts renal prognosis in native kidneys, but data are conflicting. We investigated its prognostic impact for graft failure (GF) in renal transplant recipients (RTR; n = 600). METHODS: UMOD concentration was measured cross-sectionally in RTR at 6.0 years [2.6-11.4] post-transplant, in matched patients with native chronic kidney disease (CKD) and healthy subjects. In 59 cases, RTR allograft biopsies were reviewed. RESULTS: During a follow-up of 5.3 years [4.5-5.7], GF had occurred in 7% of RTR. Median UMOD excretion (mg/24 h) was 20.4 in RTR, 11.6 in CKD and 5.7 in controls (p < 0.001). There was a curvilinear association between UMOD excretion and baseline renal function (p < 0.003) and death-censored GF, with 5.5, 11.5 and 4.0% of the cases in subsequent UMOD excretion tertiles, respectively (p = 0.002). On multivariate Cox regression analysis, hazard ratios for GF for the 1st and 3rd tertiles were 0.37 (p = 0.01) and 0.21 (p = 0.001), respectively. Interstitial fibrosis and tubular atrophy were more severe in the middle tertile (p = 0.007). CONCLUSIONS: Urinary UMOD is elevated in RTR and associated with graft function, morphology and outcome in a bimodal fashion. Dissection of the disparate mechanisms of GF prediction by urinary UMOD might provide new clues for its alleged pathogenetic significance in progressive renal function loss.
BACKGROUND: Urinary uromodulin (UMOD) predicts renal prognosis in native kidneys, but data are conflicting. We investigated its prognostic impact for graft failure (GF) in renal transplant recipients (RTR; n = 600). METHODS:UMOD concentration was measured cross-sectionally in RTR at 6.0 years [2.6-11.4] post-transplant, in matched patients with native chronic kidney disease (CKD) and healthy subjects. In 59 cases, RTR allograft biopsies were reviewed. RESULTS: During a follow-up of 5.3 years [4.5-5.7], GF had occurred in 7% of RTR. Median UMOD excretion (mg/24 h) was 20.4 in RTR, 11.6 in CKD and 5.7 in controls (p < 0.001). There was a curvilinear association between UMOD excretion and baseline renal function (p < 0.003) and death-censored GF, with 5.5, 11.5 and 4.0% of the cases in subsequent UMOD excretion tertiles, respectively (p = 0.002). On multivariate Cox regression analysis, hazard ratios for GF for the 1st and 3rd tertiles were 0.37 (p = 0.01) and 0.21 (p = 0.001), respectively. Interstitial fibrosis and tubular atrophy were more severe in the middle tertile (p = 0.007). CONCLUSIONS: Urinary UMOD is elevated in RTR and associated with graft function, morphology and outcome in a bimodal fashion. Dissection of the disparate mechanisms of GF prediction by urinary UMOD might provide new clues for its alleged pathogenetic significance in progressive renal function loss.
Authors: Pranav S Garimella; Bertrand L Jaber; Hocine Tighiouart; Orfeas Liangos; Michael R Bennett; Prasad Devarajan; Tarek M El-Achkar; Mark J Sarnak Journal: Clin J Am Soc Nephrol Date: 2016-10-26 Impact factor: 8.237
Authors: Pranav S Garimella; Traci M Bartz; Joachim H Ix; Michel Chonchol; Michael G Shlipak; Prasad Devarajan; Michael R Bennett; Mark J Sarnak Journal: Am J Kidney Dis Date: 2016-10-28 Impact factor: 8.860
Authors: Pranav S Garimella; Mary L Biggs; Ronit Katz; Joachim H Ix; Michael R Bennett; Prasad Devarajan; Bryan R Kestenbaum; David S Siscovick; Majken K Jensen; Michael G Shlipak; Paulo H M Chaves; Mark J Sarnak Journal: Kidney Int Date: 2015-07-08 Impact factor: 10.612
Authors: Dominik Steubl; Matthias Block; Victor Herbst; Wolfgang Andreas Nockher; Wolfgang Schlumberger; Robin Satanovskij; Susanne Angermann; Anna-Lena Hasenau; Lynne Stecher; Uwe Heemann; Lutz Renders; Jürgen Scherberich Journal: Medicine (Baltimore) Date: 2016-03 Impact factor: 1.889
Authors: Pranav S Garimella; Ronit Katz; Joachim H Ix; Linda F Fried; Stephen B Kritchevsky; Prasad Devarajan; Michael R Bennett; Chirag R Parikh; Michael G Shlipak; Tamara B Harris; Orlando M Gutiérrez; Mark J Sarnak Journal: Clin Nephrol Date: 2017-06 Impact factor: 0.975
Authors: Sherry G Mansour; Caroline Liu; Yaqi Jia; Peter P Reese; Isaac E Hall; Tarek M El-Achkar; Kaice A LaFavers; Wassim Obeid; Avi Z Rosenberg; Parnaz Daneshpajouhnejad; Mona D Doshi; Enver Akalin; Jonathan S Bromberg; Meera N Harhay; Sumit Mohan; Thangamani Muthukumar; Bernd Schröppel; Pooja Singh; Joe M El-Khoury; Francis L Weng; Heather R Thiessen-Philbrook; Chirag R Parikh Journal: Transplantation Date: 2021-04-01 Impact factor: 4.939